Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoxin Li

Showing results (401-410 of 438) with videos related to

Pageof 44
Sort By:
The Journal of Clinical Investigation|January 25, 2024
Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancerZepang Sun, Taojun Zhang, M Usman Ahmad, et al.
Scientific Reports|June 18, 2017
RUFY3 interaction with FOXK1 promotes invasion and metastasis in colorectal cancerRuyi Xie, Jing Wang, Xuehua Liu, et al.
Signal Transduction and Targeted Therapy|August 25, 2024
Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal dataZifan Chen, Yang Chen, Yu Sun, et al.
Cell Death & Disease|May 24, 2023
The HOXD9-mediated PAXIP1-AS1 regulates gastric cancer progression through PABPC1/PAK1 modulationJiaying Li, Miaomiao Pei, Wushuang Xiao, et al.
Eclinicalmedicine|August 21, 2025
Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 studyLiying Zhao, Hao Liu, Jiang Yu, et al.
Journal for Immunotherapy of Cancer|January 5, 2024
Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter studyWeicai Huang, Wenjun Xiong, Lei Tang, et al.
Nature Communications|April 23, 2026
Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trialLiying Zhao, Hao Liu, Yanfeng Hu, et al.
Theranostics|January 8, 2019
Erratum: MicroRNA-647 targets SRF-MYH9 axis to suppress invasion and metastasis of gastric cancer: ErratumGengtai Ye, Kunzhai Huang, Jiang Yu, et al.
Theranostics|September 14, 2017
MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric CancerGengtai Ye, Kunzhai Huang, Jiang Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2025
Foundation Model for Predicting Prognosis and Adjuvant Therapy Benefit From Digital Pathology in GI CancersXiyue Wang, Yuming Jiang, Sen Yang, et al.
Pageof 44

Showing results (401-410 of 438) with videos related to

Sort By:
Pageof 44
The Journal of Clinical Investigation|January 25, 2024
Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancerZepang Sun, Taojun Zhang, M Usman Ahmad, et al.
Scientific Reports|June 18, 2017
RUFY3 interaction with FOXK1 promotes invasion and metastasis in colorectal cancerRuyi Xie, Jing Wang, Xuehua Liu, et al.
Signal Transduction and Targeted Therapy|August 25, 2024
Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal dataZifan Chen, Yang Chen, Yu Sun, et al.
Cell Death & Disease|May 24, 2023
The HOXD9-mediated PAXIP1-AS1 regulates gastric cancer progression through PABPC1/PAK1 modulationJiaying Li, Miaomiao Pei, Wushuang Xiao, et al.
Eclinicalmedicine|August 21, 2025
Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 studyLiying Zhao, Hao Liu, Jiang Yu, et al.
Journal for Immunotherapy of Cancer|January 5, 2024
Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter studyWeicai Huang, Wenjun Xiong, Lei Tang, et al.
Nature Communications|April 23, 2026
Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trialLiying Zhao, Hao Liu, Yanfeng Hu, et al.
Theranostics|January 8, 2019
Erratum: MicroRNA-647 targets SRF-MYH9 axis to suppress invasion and metastasis of gastric cancer: ErratumGengtai Ye, Kunzhai Huang, Jiang Yu, et al.
Theranostics|September 14, 2017
MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric CancerGengtai Ye, Kunzhai Huang, Jiang Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2025
Foundation Model for Predicting Prognosis and Adjuvant Therapy Benefit From Digital Pathology in GI CancersXiyue Wang, Yuming Jiang, Sen Yang, et al.
Pageof 44